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ABSTRACT
Aims of MINAP To audit the quality of care of patients
with acute coronary syndrome and provide a resource for
academic research.
Quality of care interventions Feedback to hospitals,
ambulance services and cardiac networks regarding
benchmarking of performance against national standards
and targets.
Setting All 230 acute hospitals in England and Wales.
Years: 2000-present.
Population Consecutive patients, unconsented. Current
number of records: 735 000.
Startpoints Any acute coronary syndrome, including
non-ST-elevation myocardial infarction, ST-elevation
myocardial infarction and unstable angina.
Baseline data 123 fields covering demographic factors,
co-morbid conditions and treatment in hospital. No blood
resource.
Data capture Manual entry by clerks, nurses or doctors
onto Lotus Notes; non-financial incentives at hospital
level.
Data quality Hospitals perform an annual data validation
study, where data are re-entered from the case notes in
20 randomly selected records that are held on the
server. In 2008 data were >90% complete for 20 key
fields, with >80% completeness for all but four of the
remaining fields.
Endpoints and linkages to other data All-cause
mortality is obtained through linkage with Office for
National Statistics. No other linkages exist at present.
Access to data Available for research and audit by
application to the MINAP Academic Group. http://www.
rcplondon.ac.uk/CLINICAL-STANDARDS/
ORGANISATION/PARTNERSHIP/Pages/MINAP-.aspx.
The Myocardial Ischaemia National Audit Project
(MINAP) is a national registry of patients admitted
to hospitals in England and Wales with acute
coronary syndromes (ACS) (ﬁgure 1). It was
established in 1998 to provide participating hospi-
tals with a common mechanism for auditing
performance against standards deﬁned in the
National Service Framework for Coronary Heart
Disease.2 Data collection began in October 2000
and by mid-2002 all acute hospitals in England and
Wales were participating in the registry.
ORGANISATION AND FUNDING
MINAP is run by a non-clinical projectmanager with
an assistant, supported by a part-time clinical
director and an associate. Oversight is provided by
a steering group that represents key stakeholders,
including professional bodies, patient groups and
national government. Data are stored and managed
by the Central Cardiac Audit Database Group
(CCAD).3 AMINAPacademic group, reporting to the
steering group,hasbeenestablished to facilitate access
to the data.4 MINAP and CCAD are funded by the
Health Quality Improvement Partnership (HQIP),
whose aim is to increase the impact of clinical audit on
the quality of care in England and Wales.5 HQIP is
currently contracted by the Department of Health to
manage the National Clinical Audit and Patient
Outcomes Programme, and receives no commercial
funding. The costs of local data entry are borne by the
participating hospitals.
THE DATA
Entering data
MINAP accrues approximately 85 000 episodes of
care per year for patients with ACS admitted to all
acute National Health Service (NHS) hospitals in
England and Wales. Most (about 80%) hospitals use
MINAP software based on Lotus Notes for entering
data, with the remainder using locally developed
software or commercial applications. Data are
uploaded to central servers managed by CCAD,
with all data encrypted before transfer. A move to
a password-protected web-based system is under
way, allowing more ﬂexible data entry from
multiple sites within a single organisation.
What is recorded?
The MINAP dataset comprises 123 separate ﬁelds6
under the following groups; patient demographics,
admission method, clinical features and investiga-
tions, medical history, drug treatment before admis-
sion, detail of primary reperfusion treatment, drug
treatment in hospital, clinical complications, inter-
ventional treatments, hospital outcome, discharge
diagnosis and discharge (secondary prevention)
treatment. The dataset is revised every 2 years to
meet the requirements of users and to respond to
developments in management of ACS. Care is taken
to maintain continuity of ﬁelds when new options
are added, and redundant ﬁelds are archived.
Patient identification
Patients are identiﬁed from their unique NHS
number which is pseudonymised within the data-
base. MINAP does not record patient addresses, but
does record other patient identiﬁers such as hospital
numbers, dates of birth and postcodes. These are
encrypted before transmission to the central data-
base. Researchers do not have access to these
sensitive data, and hospital identity is usually
protected. However, age at the time of the index
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event is provided and eastings and northings of the centroid of
the output area of residence, shared by between one and 80
addresses, can be made available for geographical mapping
(see ﬁgure 1) with necessary permissions.
Data quality
Oversight
MINAP provides guidance and technical advice for staff entering
data, via a dedicated telephone helpdesk. The MINAP data
application has error-checking routines, including range and
consistency checks, designed to minimise common errors.
Validation
An annual data validation exercise requires every hospital to re-
enter 20 data items from the medical records of 20 randomly
selected patients, using a specially designed data validation tool.
Agreement scores are fed back to hospitals with advice on how
to improve performance. Agreement varies between ﬁelds (high
in key ﬁelds, slightly lower elsewhere) but the median level of
agreement between MINAP data and re-audit data (across all
hospitals) has risen from 72% in 20037 to 89.5% in 2008.8
Completeness
Online data completeness views are available within the MINAP
database. The completeness of 20 key ﬁelds is closely monitored
and is generally above 95%; these ﬁelds include NHS number,
discharge diagnosis, hospital mortality and secondary prevention
medication prescribed at discharge. In other ﬁelds the
completeness of data entry, as recorded in 2008, was generally
over 80% (table 1) and has been rising since MINAP ’s inception.
Data dictionary
A data dictionary is maintained, containing explanatory detail
and notes on all ﬁelds.
Patient capture
Participating hospitals are requested to enter all ACS patients.
In practice, MINAP probably records the great majority of
ST-elevation myocardial infarctions (STEMIs) admitted to hospital
in England and Wales, but signiﬁcantly fewer non-ST-elevation
myocardial infarctions (non-STEMIs). Hospital Episode Statis-
tics (HES) reports w110 000 hospital admissions with myocar-
dial infarction in England9; MINAP recordsw27 000 STEMIs per
year, but only w45 000 non-STEMIs. From internal data,
w80 000 non-STEMIs per year would be an appropriate expec-
tation. Under-reporting of non-STEMI varies between hospitals
and may reﬂect variation in resources allocated to data capture,
particularly the systematic identiﬁcation of patients with
possible ACS who have not been admitted to cardiac wards.10
Data linkage
MINAP does not collect follow-up data but is linked to the
Ofﬁce for National Statistics’ (ONS) registry and uses each
patient’s unique NHS number to obtain regular mortality
updates. It is possible to link MINAP data with other databases
stored by CCAD, including the coronary interventional database
held by the British Cardiovascular Interventional Society (BCIS),
and the surgical data held by the Society of Cardiothoracic
Surgeons.11 12
USE OF MINAP DATA
Audit
MINAP is primarily an audit tooldproviding participating
hospitals with a record of ACS management against nationally
agreed standards of care. A set of analyses describing perfor-
mance in key areas is updated every 24 hours and made available
to hospitals and ambulance services. Participating hospitals can
only view analyses relating to their own patients compared to
national aggregate data. In addition, hospitals can generate
quarterly audit reports and are able to download their own data
into a spreadsheet for local analyses.
Additional analyses are provided to cardiac networks repre-
senting groups of hospitals, the strategic health authorities who
Figure 1 Map to show location of 366 487 STEMIs and non-STEMIs
recorded in MINAP, 2003e2006. Source: 1991 Census: Digitised
Boundary Data (England and Wales).1
Table 1 Completeness of key clinical fields in 2008
Data group Completeness of fields
Demographic details >95%
Details of admissiony >95%
Previous medical history >90%
Timing of critical events
Date/time of onset of symptoms 85%
Date/time of arrival in hospital 100%
Date/time of reperfusion treatment 92%
Drug use on admission >90%
Clinical features and non-invasive
investigations*
>80%
Drug use in hospital >85%
Discharge medications >85%
Complications; bleeding, re-infarction,
cardiac arrest
>80%
Other invasive investigations >80%
Discharge details >80%
Poorly completed fields within clinical features*:
Cholesterol 64%
Ejection fraction 59%
Weight 48%
Height 31%
*Four fields within clinical features had poor completeness (cholesterol, ejection fraction,
weight, height); these are shown separately.
yDetails of admission include method of admission and admission diagnosis.
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manage the NHS at a regional level, and the Care Quality
Commission who monitor quality of care within the NHS in
England. An annual public report How the NHS manages Heart
Attacks is published,13 which provides longitudinal analyses
identifying improvements in national performance. MINAP also
works with professional bodies and policy-makers such as the
National Institute for Health and Clinical Excellence to provide
data that inform new management strategies.
Research
Clinicians are able to download their local hospital data for
research and additional observational studies have been under-
taken by the project team. Recently, the MINAP Academic
Group, based within the National Institute for Clinical
Outcomes Research at University College London, has been
established to coordinate a broad research strategy that draws on
the major strengths of the data collection including its size and
national reach. A governance framework has been developed and
mechanisms for submission and assessment of external research
proposals are now available in order to increase access to the
registry and maximise its research potential.4 Investigators are
conducting research across a range of themes including registry
methodology, healthcare delivery and outcomes, and disease-
environment interactions. The potential for linkage to other
national registries in primary and secondary care is being
explored in order to enrich the dataset and allow development of
a longitudinal patient record. International collaborations are
also being established in order to understand how different
systems of healthcare delivery might affect management and
prognosis of ACS.
Examples of MINAP data in audit and research
One of the ﬁrst publications using MINAP data addressed one of
the original NSF targets2; it showed that the speed of treatment
for STEMI patients improved and the proportion given throm-
bolysis increased between 1997 and 2002.14 More recently, Gale
et al15 reported that aspirin use and pre-hospital thrombolysis
predicted survival in patients with STEMI, while increasing age,
systolic blood pressure and heart rate predicted mortality. A full
list of publications using MINAP data is available online.4
STRENGTHS AND WEAKNESSES
The size and national reach of the MINAP registry underpin its
value as an audit and research tool. The representativeness to the
whole of England and Wales is a key strength owing to the
willing collaboration of cardiac units across England and Wales
in submitting their data, but this is also MINAP ’s greatest
challenge (see below). In auditing hospital performance against
national guidelines, MINAP has been the driver for substantial
improvements in ACS care and outcomes, longitudinal analyses
after its inception demonstrating year by year increases in use of
evidence-based treatments and decreasing 30-day mortality
rates.16 With over 735 000 ACS admissions recorded, and with
every acute hospital in England and Wales submitting data,
MINAP has the power to answer research questions relevant to
small subsets and to provide comparative analyses at hospital,
regional and international levels. However, MINAP shares the
weaknesses of most other large data collections, particularly in
the compromise between the number of constituent ﬁelds and
the willingness of collaborators to enter data. Inherent in this
trade-off is the variable availability of information either because
it was not asked for or not entered (see above and table 1). Other
weaknesses include outcome data, which, though available
through linkage with ONS for all patients, does not specify the
cause of death and is presently limited to vital status. In addi-
tion, MINAP records limited biochemical data, no data regarding
the outcome of angiographies, no genetic data and provides no
blood resource for testing new biomarkers.
CHALLENGES
The MINAP dataset must keep abreast of changing recom-
mendations for patient care while recognising that these
conspire against complete data entry and qualitydfor example,
it takes approximately 2 years for data entry into a newly
introduced ﬁeld to reach 90% completeness. A consequence of
the increasingly interventional approach to ACS management is
that many patients (with both STEMI and non-STEMI) are now
transferred between hospitals during the index event, making
data capture difﬁcult. Increasingly closer collaboration between
MINAP and the BCIS registry has the potential to reduce double
data collection, while the threat to data capture of inter-hospital
transfers is now addressed by linking MINAP records between
hospitals. Funding is also a challenge for MINAP and the likely
need for self-funding in the future cannot be ignored. Mean-
while, local data collection will continue to be variably resourced
by individual hospital trusts where there is often over-reliance
on the goodwill of those who collect and input the data.
CONCLUSIONS
MINAP has evolved over a decade in response to changes in the
management of ACS and has data on over 735 000 admissions. It
has complete national coverage in England and Wales and has
maintained the support of clinicians through involvement with
a range of professional, lay and government organisations. While
it is a valuable and growing resource for researchers, its primary
aim remains the promotion of high quality care for patients
with heart attack.
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